Vol 11, No 11 (November 29, 2022) - Translational Lung Cancer Research

Editorial

Multiple mutations in the EGFR gene in lung cancer is rare but should not be forgettable

Ryo Miyata, Masatsugu Hamaji

Translational Lung Cancer Research

2022;

(11)

:2167-2169

(29 November 2022)

PDF Full Text (1652) COI Form Open Access

Re-administration of immune checkpoint inhibitors for patients with non-small cell lung cancer

Taiki Hakozaki

Translational Lung Cancer Research

2022;

(11)

:2170-2174

(29 November 2022)

PDF Full Text (1663) COI Form Open Access

Targeted intraoperative fluorescence imaging for the visualization of ground-glass nodules in the lung

Hak Soo Choi, Jun Hee Lee, Hyun Koo Kim

Translational Lung Cancer Research

2022;

(11)

:2175-2177

(29 November 2022)

PDF Full Text (943) COI Form Open Access

What is the real value of predictive models?

Maria Rodriguez, Lucia Milla

Translational Lung Cancer Research

2022;

(11)

:2178-2180

(29 November 2022)

PDF Full Text (1059) COI Form Open Access

Original Article

Development and verification of new monoclonal orthopedia homeobox (OTP) specific antibodies for pulmonary carcinoid diagnostics

Laura Moonen, Jules L. Derks, Lisa M. V. Lap, Britney J. C. A. Marijnissen, Lisa M. Hillen, Michael A. den Bakker, Jan H. von der Thüsen, Robert-Jan van Suylen, Wim Timens, Maria Bintanel, Eugenia Kuteeva, Anne-Marie C. Dingemans, Ernst-Jan M. Speel

Translational Lung Cancer Research

2022;

(11)

:2181-2191

(29 November 2022)

PDF Full Text (2001) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Immune profile analysis of peripheral blood and tumors of lung cancer patients treated with immune checkpoint inhibitors

Yoshinobu Ichiki, Takashi Fukuyama, Mari Ueno, Yoshiro Kanasaki, Hidenori Goto, Mai Takahashi, Shuji Mikami, Noritada Kobayashi, Kozo Nakanishi, Shinichi Hayashi, Tsuyoshi Ishida

Translational Lung Cancer Research

2022;

(11)

:2192-2207

(29 November 2022)

PDF Full Text (2412) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Association of thyroid transcription factor-1 (TTF-1) expression with efficacy of PD-1/PD-L1 inhibitors plus pemetrexed and platinum chemotherapy in advanced non-squamous non-small cell lung cancer

Ritsu Ibusuki, Yasuto Yoneshima, Mikiko Hashisako, Norikazu Matsuo, Taishi Harada, Yuko Tsuchiya-Kawano, Junji Kishimoto, Keiichi Ota, Yoshimasa Shiraishi, Eiji Iwama, Kentaro Tanaka, Yoshinao Oda, Isamu Okamoto

Translational Lung Cancer Research

2022;

(11)

:2208-2215

(29 November 2022)

PDF Full Text (5852) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1-rearranged NSCLC

Francesca Ruzzi, Stefania Angelicola, Lorena Landuzzi, Elena Nironi, Maria Sofia Semprini, Laura Scalambra, Annalisa Altimari, Elisa Gruppioni, Michelangelo Fiorentino, Francesca Giunchi, Manuela Ferracin, Annalisa Astolfi, Valentina Indio, Andrea Ardizzoni, Francesco Gelsomino, Patrizia Nanni, Pier-Luigi Lollini, Arianna Palladini

Translational Lung Cancer Research

2022;

(11)

:2216-2229

(29 November 2022)

PDF Full Text (1898) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Multimodal therapy of epithelioid pleural mesothelioma: improved survival by changing the surgical treatment approach

Laura V. Klotz, Hans Hoffmann, Rajiv Shah, Florian Eichhorn, Christiane Gruenewald, Elena L. Bulut, Raffaella Griffo, Thomas Muley, Petros Christopoulos, Philip Baum, Peter Huber, Seyer Safi, Marc Kriegsmann, Michael Thomas, Helge Bischoff, Hauke Winter, Martin E. Eichhorn

Translational Lung Cancer Research

2022;

(11)

:2230-2242

(29 November 2022)

PDF Full Text (3967) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Multi-omics consensus portfolio to refine the classification of lung adenocarcinoma with prognostic stratification, tumor microenvironment, and unique sensitivity to first-line therapies

Yanmei Zou, Chenlin Cao, Yali Wang, Yilu Zhou, Shuo Yao, Lili Zhang, Kun Zheng, Hong Zhang, Wan Qin, Kai Qin, Huihua Xiong, Xianglin Yuan, Shengling Fu, Yihua Wang, Hua Xiong

Translational Lung Cancer Research

2022;

(11)

:2243-2260

(29 November 2022)

PDF Full Text (3911) Reporting Checklist COI Form Open Access

Development and validation of the artificial intelligence (AI)-based diagnostic model for bronchial lumen identification

Ying Li, Xiaoxuan Zheng, Fangfang Xie, Lin Ye, Elena Bignami, Yasmeen K. Tandon, María Rodríguez, Yun Gu, Jiayuan Sun

Translational Lung Cancer Research

2022;

(11)

:2261-2274

(29 November 2022)

PDF Full Text (2266) Reporting Checklist Data Sharing Statement COI Form Open Access

Establishment and validation of a nomogram model for predicting postoperative recurrence-free survival in stage IA3 lung adenocarcinoma: a retrospective cohort study

Shaobin Yu, Chengxiong You, Renhe Yan, Hui Chen, Chao Chen, Shaojun Xu, Michel Gonzalez, Ruiqin Chen, Mingqiang Kang, Shuchen Chen

Translational Lung Cancer Research

2022;

(11)

:2275-2288

(29 November 2022)

PDF Full Text (1509) Reporting Checklist Data Sharing Statement COI Form Open Access

Safety and efficacy of immunotherapy rechallenge following checkpoint inhibitor-related pneumonitis in advanced lung cancer patients: a retrospective multi-center cohort study

Xinqing Lin, Haiyi Deng, Tianqing Chu, Likun Chen, Yilin Yang, Guihuan Qiu, Xiaohong Xie, Yinyin Qin, Ming Liu, Zhanhong Xie, Ming Ouyang, Shiyue Li, Yong Song, Francesco Petrella, Marko Jakopovic, Nikolaos Tsoukalas, Piergiorgio Solli, Taichiro Goto, Yuichi Saito, Chengzhi Zhou

Translational Lung Cancer Research

2022;

(11)

:2289-2305

(29 November 2022)

PDF Full Text (2932) Reporting Checklist Data Sharing Statement COI Form Open Access

Treatment response and safety of immunotherapy for advanced non-small cell lung cancer with comorbid chronic obstructive pulmonary disease: a retrospective cohort study

Kening Zhang, Chengzhi Zhou, Jiabo Gao, Pei Yu, Xinqing Lin, Xiaohong Xie, Ming Liu, Jiexia Zhang, Zhanhong Xie, Fei Cui, Shiyue Li, Francesco Passiglia, Giulia Maria Stella, Yinyin Qin

Translational Lung Cancer Research

2022;

(11)

:2306-2317

(29 November 2022)

PDF Full Text (2395) Reporting Checklist Data Sharing Statement COI Form Open Access

Consensus

Expert consensus on indocyanine green fluorescence imaging for thoracoscopic lung resection (The Version 2022)

Fei Cui, Jun Liu, Ming Du, Junqiang Fan, Junke Fu, Qing Geng, Ming He, Jian Hu, Bin Li, Shanqing Li, Xukai Li, Yong-De Liao, Ling Lin, Feng Liu, Jian Liu, Junhong Lv, Qiang Pu, Lijie Tan, Hui Tian, Mingsong Wang, Tao Wang, Li Wei, Chuan Xu, Shidong Xu, Shun Xu, Haoxian Yang, Ben-Tong Yu, Guangmao Yu, Zhentao Yu, Chang Young Lee, Eugenio Pompeo, Feredun Azari, Hitoshi Igai, Hyun Koo Kim, Marco Andolfi, Masatsugu Hamaji, Massimiliano Bassi, Wolfram Karenovics, Yojiro Yutaka, Yoshihisa Shimada, Yukinori Sakao, Alan D. L. Sihoe, Yi Zhang, Zhenfa Zhang, Jun Zhao, Wenzhao Zhong, Yuming Zhu, Jianxing He

Translational Lung Cancer Research

2022;

(11)

:2318-2331

(29 November 2022)

PDF Full Text (4862) COI Form Open Access

Review Article

Onco-biome in pharmacotherapy for lung cancer: a narrative review

Akiko T. Tateishi, Yusuke Okuma

Translational Lung Cancer Research

2022;

(11)

:2332-2345

(29 November 2022)

PDF Full Text (1872) Reporting Checklist Peer Review File COI Form Open Access

iMDT Corner

Immune thrombocytopenia in a small cell lung cancer patient treated with atezolizumab: a case report

Guihuan Qiu, Suyang Li, Bingliang Li, Qingqing Yang, Haiyi Deng, Yilin Yang, Xiaohong Xie, Xinqing Lin, Nobuhiko Seki, Satoru Miura, Takehito Shukuya, Chengzhi Zhou, Ming Liu

Translational Lung Cancer Research

2022;

(11)

:2346-2355

(29 November 2022)

PDF Full Text (2990) Reporting Checklist COI Form Open Access